Federal health officials are seeking a open for mobile app designs that would assistance bond opioid abusers to carriers of a remedy drug naloxone, that can assistance retreat overdose. In 2014, 2 million Americans were contingent on opioids and 28,000 died of opioid overdose, according to a Substance Abuse and Mental Health Services Administration.
The Food and Drug Administration (FDA) launched a 2016 Naloxone App Competition on Monday to partisan “computer programmers, open health advocates, clinical researchers, entrepreneurs and innovators from all disciplines” to emanate apps that would assist in a national opioid abuse epidemic, according to a news release.
“With a thespian boost in a series of opioid overdose deaths in a U.S., there’s a critical need to strap a energy of new technologies to fast and effectively couple people experiencing an overdose— or a bystander such as a crony or family member— with someone who carries and can discharge a life-saving medication,” pronounced FDA Commissioner Dr. Robert M. Califf. “Through this competition, we are drumming open health-focused innovators to assistance move technological solutions to a real-world problem that is costing a U.S. thousands of lives any year.”
According to a Centers for Disease Control and Prevention, naloxone accessibility scarcely tripled between 2010 and 2014, though people and their desired ones might not always have a life-saving drug on palm or know where to get it in a eventuality of an overdose.
“The idea of this foe is to rise a low-cost, scalable, crowd-sourced mobile focus that addresses this emanate of accessibility,” Dr. Peter Lurie, associate commissioner for open health plan and research during a FDA, pronounced in a release. “Mobile phone applications have been grown to teach laypersons on how to commend an overdose and discharge naloxone, and to bond bystanders with people in need of other medical services, such as CPR. To date, however, no focus is accessible to bond carriers of naloxone with circuitously opioid overdose victims.”
The foe is partial of a FDA’s Opioids movement Plan and a U.S. Department of Health and Human Services’ Opioid Initiative.
Registration for a foe ends Friday, Oct. 7. For some-more information, visit FDA.gov.